Cargando…

Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects

Lysergic acid diethylamide (LSD) is a classic psychedelic, 3,4-methylenedioxymethamphetamine (MDMA) is an empathogen, and d-amphetamine is a classic stimulant. All three substances are used recreationally. LSD and MDMA are being investigated as medications to assist psychotherapy, and d-amphetamine...

Descripción completa

Detalles Bibliográficos
Autores principales: Holze, Friederike, Vizeli, Patrick, Müller, Felix, Ley, Laura, Duerig, Raoul, Varghese, Nimmy, Eckert, Anne, Borgwardt, Stefan, Liechti, Matthias E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969135/
https://www.ncbi.nlm.nih.gov/pubmed/31733631
http://dx.doi.org/10.1038/s41386-019-0569-3
_version_ 1783489277264396288
author Holze, Friederike
Vizeli, Patrick
Müller, Felix
Ley, Laura
Duerig, Raoul
Varghese, Nimmy
Eckert, Anne
Borgwardt, Stefan
Liechti, Matthias E.
author_facet Holze, Friederike
Vizeli, Patrick
Müller, Felix
Ley, Laura
Duerig, Raoul
Varghese, Nimmy
Eckert, Anne
Borgwardt, Stefan
Liechti, Matthias E.
author_sort Holze, Friederike
collection PubMed
description Lysergic acid diethylamide (LSD) is a classic psychedelic, 3,4-methylenedioxymethamphetamine (MDMA) is an empathogen, and d-amphetamine is a classic stimulant. All three substances are used recreationally. LSD and MDMA are being investigated as medications to assist psychotherapy, and d-amphetamine is used for the treatment of attention-deficit/hyperactivity disorder. All three substances induce distinct acute subjective effects. However, differences in acute responses to these prototypical psychoactive substances have not been characterized in a controlled study. We investigated the acute autonomic, subjective, and endocrine effects of single doses of LSD (0.1 mg), MDMA (125 mg), d-amphetamine (40 mg), and placebo in a randomized, double-blind, cross-over study in 28 healthy subjects. All of the substances produced comparable increases in hemodynamic effects, body temperature, and pupil size, indicating equivalent autonomic responses at the doses used. LSD and MDMA increased heart rate more than d-amphetamine, and d-amphetamine increased blood pressure more than LSD and MDMA. LSD induced significantly higher ratings on the 5 Dimensions of Altered States of Consciousness scale and Mystical Experience Questionnaire than MDMA and d-amphetamine. LSD also produced greater subjective drug effects, ego dissolution, introversion, emotional excitation, anxiety, and inactivity than MDMA and d-amphetamine. LSD also induced greater impairments in subjective ratings of concentration, sense of time, and speed of thinking compared with MDMA and d-amphetamine. MDMA produced greater ratings of good drug effects, liking, high, and ego dissolution compared with d-amphetamine. d-Amphetamine increased ratings of activity and concentration compared with LSD. MDMA but not LSD or d-amphetamine increased plasma concentrations of oxytocin. None of the substances altered plasma concentrations of brain-derived neurotrophic factor. These results indicate clearly distinct acute effects of LSD, MDMA, and d-amphetamine and may assist the dose-finding in substance-assisted psychotherapy research.
format Online
Article
Text
id pubmed-6969135
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-69691352020-01-22 Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects Holze, Friederike Vizeli, Patrick Müller, Felix Ley, Laura Duerig, Raoul Varghese, Nimmy Eckert, Anne Borgwardt, Stefan Liechti, Matthias E. Neuropsychopharmacology Article Lysergic acid diethylamide (LSD) is a classic psychedelic, 3,4-methylenedioxymethamphetamine (MDMA) is an empathogen, and d-amphetamine is a classic stimulant. All three substances are used recreationally. LSD and MDMA are being investigated as medications to assist psychotherapy, and d-amphetamine is used for the treatment of attention-deficit/hyperactivity disorder. All three substances induce distinct acute subjective effects. However, differences in acute responses to these prototypical psychoactive substances have not been characterized in a controlled study. We investigated the acute autonomic, subjective, and endocrine effects of single doses of LSD (0.1 mg), MDMA (125 mg), d-amphetamine (40 mg), and placebo in a randomized, double-blind, cross-over study in 28 healthy subjects. All of the substances produced comparable increases in hemodynamic effects, body temperature, and pupil size, indicating equivalent autonomic responses at the doses used. LSD and MDMA increased heart rate more than d-amphetamine, and d-amphetamine increased blood pressure more than LSD and MDMA. LSD induced significantly higher ratings on the 5 Dimensions of Altered States of Consciousness scale and Mystical Experience Questionnaire than MDMA and d-amphetamine. LSD also produced greater subjective drug effects, ego dissolution, introversion, emotional excitation, anxiety, and inactivity than MDMA and d-amphetamine. LSD also induced greater impairments in subjective ratings of concentration, sense of time, and speed of thinking compared with MDMA and d-amphetamine. MDMA produced greater ratings of good drug effects, liking, high, and ego dissolution compared with d-amphetamine. d-Amphetamine increased ratings of activity and concentration compared with LSD. MDMA but not LSD or d-amphetamine increased plasma concentrations of oxytocin. None of the substances altered plasma concentrations of brain-derived neurotrophic factor. These results indicate clearly distinct acute effects of LSD, MDMA, and d-amphetamine and may assist the dose-finding in substance-assisted psychotherapy research. Springer International Publishing 2019-11-16 2020-02 /pmc/articles/PMC6969135/ /pubmed/31733631 http://dx.doi.org/10.1038/s41386-019-0569-3 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Holze, Friederike
Vizeli, Patrick
Müller, Felix
Ley, Laura
Duerig, Raoul
Varghese, Nimmy
Eckert, Anne
Borgwardt, Stefan
Liechti, Matthias E.
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
title Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
title_full Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
title_fullStr Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
title_full_unstemmed Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
title_short Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
title_sort distinct acute effects of lsd, mdma, and d-amphetamine in healthy subjects
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969135/
https://www.ncbi.nlm.nih.gov/pubmed/31733631
http://dx.doi.org/10.1038/s41386-019-0569-3
work_keys_str_mv AT holzefriederike distinctacuteeffectsoflsdmdmaanddamphetamineinhealthysubjects
AT vizelipatrick distinctacuteeffectsoflsdmdmaanddamphetamineinhealthysubjects
AT mullerfelix distinctacuteeffectsoflsdmdmaanddamphetamineinhealthysubjects
AT leylaura distinctacuteeffectsoflsdmdmaanddamphetamineinhealthysubjects
AT duerigraoul distinctacuteeffectsoflsdmdmaanddamphetamineinhealthysubjects
AT varghesenimmy distinctacuteeffectsoflsdmdmaanddamphetamineinhealthysubjects
AT eckertanne distinctacuteeffectsoflsdmdmaanddamphetamineinhealthysubjects
AT borgwardtstefan distinctacuteeffectsoflsdmdmaanddamphetamineinhealthysubjects
AT liechtimatthiase distinctacuteeffectsoflsdmdmaanddamphetamineinhealthysubjects